Researchers including one of Indian-origin have developed a technology that may aid in driving drugs or nanoparticles to injured areas of the brain leading to new therapeutics for traumatic brain injuries. Current interventions for acute brain injury are aimed at stabilising the patient by reducing intracranial pressure and maintaining blood flow but there are no approved drugs to stop the cascade of events that cause secondary injury said lead author Aman Mann post-doctoral researcher at Sanford Burnham Prebys Medical Discovery Institute (SBP) in the US. The researchers found a peptide sequence of four amino acids cysteine alanine glutamine and lysine
